Literature DB >> 18035130

Prospects for development and potential impact of a vaccine against congenital cytomegalovirus (CMV) infection.

Mark R Schleiss1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18035130     DOI： 10.1016/j.jpeds.2007.07.015

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  6 in total

1.  Structure of human cytomegalovirus UL144, an HVEM orthologue, bound to the B and T cell lymphocyte attenuator.

Authors:  Aruna Bitra; Ivana Nemčovičová; Gaelle Picarda; Tzanko Doukov; Jing Wang; Chris A Benedict; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2019-05-24       Impact factor: 5.157

2.  Assessment of parental acceptance of a potential cytomegalovirus vaccine for adolescent females.

Authors:  Tiffany J Petty; S Todd Callahan; Qingxia Chen; Kathryn M Edwards; Amanda F Dempsey
Journal:  Vaccine       Date:  2010-06-30       Impact factor: 3.641

3.  Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus.

Authors:  Jie Zhong; Michael Rist; Leanne Cooper; Corey Smith; Rajiv Khanna
Journal:  PLoS One       Date:  2008-09-22       Impact factor: 3.240

4.  The development of Chinese specific human cytomegalovirus polyepitope recombinant vaccine.

Authors:  Ping Zhao; Dao-Xin Ma; Shuang Yu; Fu-Zhong Xue; Wei-Wei Zhu; Na Shao; Jing-Ru Zhang; Chun-Yan Ji
Journal:  Antiviral Res       Date:  2011-12-13       Impact factor: 5.970

5.  Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses.

Authors:  Wendell Smith; Peter Tomasec; Rebecca Aicheler; Andrea Loewendorf; Ivana Nemčovičová; Eddie C Y Wang; Richard J Stanton; Matt Macauley; Paula Norris; Laure Willen; Eva Ruckova; Akio Nomoto; Pascal Schneider; Gabriele Hahn; Dirk M Zajonc; Carl F Ware; Gavin W G Wilkinson; Chris A Benedict
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

6.  Structure of human cytomegalovirus UL141 binding to TRAIL-R2 reveals novel, non-canonical death receptor interactions.

Authors:  Ivana Nemčovičová; Chris A Benedict; Dirk M Zajonc
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.